Author： Craig A. Vanstone D. Agrawal S.
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.10, 1997-10, pp. : 1175-1182
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Patent strategies for therapeutic RNAi
By Highlander Steven L Wohlers Travis M
Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 11, 2008-11 ,pp. :
Access to resources
Recommend
Antisense oligonucleotide therapeutics
By Bennett C.F.
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. :
Antisense Anticancer Oligonucleotide Therapeutics
Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-01 ,pp. :
Antisense Oligonucleotide Drug Design
Current Pharmaceutical Design, Vol. 10, Iss. 7, 2004-03 ,pp. :